De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor |
Feinstein Institute for Medical Research - North Shore / Marc Symons, PhD |
Innovation Grants |
2017 |
New York |
Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML |
Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD |
Innovation Grants |
2017 |
Washington |
Pediatric Precision Oncology: Parent and Adolescent Experiences |
Hospital for Sick Children / Anita Villani, MD |
Psychosocial Launch Grant |
2017 |
Ontario |
Mechanisms of OTX2 Mediated Chromatin Regulation in Medulloblastoma |
Massachusetts General Hospital / Miguel Rivera, MD |
Innovation Grants |
2017 |
Massachusetts |
Therapeutic Targeting of PGBD5-induced DNA Repair Dependency in Pediatric Solid Tumors |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD |
Reach Grants |
2017 |
New York |
A Home Physical Activity Program to Improve Cognitive Late Effects in Children Treated with Radiation for Brain Tumors |
National Cancer Institute / Pamela Wolters, PhD |
Psychosocial Family Impact Grant |
2017 |
Maryland |
Identification and Targeting of Microenvironmental Factors Controlling Pediatric Leukemia |
New York University School of Medicine / Anastasia Tikhonova, PhD |
Young Investigator Grants |
2017 |
New York |
Preclinical Efficacy of Daratumumab in T Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Karen Bride, MD/PhD |
Young Investigator Grants |
2017 |
New York |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
Long Non-Coding RNAs as Novel Biomarkers and Therapeutic Targets in Pediatric Leukemia |
New York University School of Medicine / Iannis Aifantis, PhD |
Innovation Grants |
2017 |
New York |